Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer Completed surveys were obtained from 685 (86%) of 797 ...

The CAPTAIN trial compared the MRI-Guided TULSA Procedure™ to robotic radical prostatectomy for localized prostate cancer.

LYON, France, April 23, 2024 - EDAP TMS SA (EDAP), the global leader in robotic energy-based therapies, announced that final results from the HIFI Study, the largest clinical trial ever conducted ...

TORONTO, March 13, 2026 (GLOBE NEWSWIRE)-- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, ...

The first direct comparison between robot-assisted laparoscopic prostatectomy and open surgery (radical retropubic prostatectomy) has ended in a tie. Early results from an international, randomized, ...

At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...

Better continence, erectile function, but data on oncologic outcomes still 2 years away ...

EDAP TMS SA announced the positive results of its Focal Ablation Versus Radical Prostatectomy (FARP) Study at the AUA Annual Meeting on April 27, 2025. The trial achieved its primary goal, ...

Robotic-assisted radical prostatectomy (RARP) for clinically localized prostate cancer is associated with lower rates of complications than retropubic radical prostatectomy (RRP), including infections ...

The probability of surgical success with telesurgery for radical prostatectomy and partial nephrectomy for small renal masses was non-inferior to local robotic surgery in a small randomized trial. The ...